according to §13 AMG (German Medicines Act) which includes the activities of secondary packaging and release of drugs.
with a wholesale permit in accordance with § 52a AMG.
equipped with mass spectrometry, IR, NIR, etc.
of specific analytical problems, also in the area of identification.
(external) according §14 AMG.
of special agents and substrates, including 13C labelled substrates such as 13C urea, etc.
of a supplementary balanced
diet for supplementation in hemodialysis patients;
HD vitamins.
of own-brand products for pharmacies.
services of all kinds.
and obtaining permits.
Sie haben die Möglichkeit, uns Nebenwirkungen zu unseren Produkten über folgende Kontaktwege zu melden:
Telefonisch: +49 5861 983258
Per E-Mail: info@danpharma.de
Mit der Übermittlung Ihrer Nebenwirkungsmeldung an uns erklären Sie Ihr Einverständnis zu unseren Datenschutzhinweisen, die Sie in unserer Datenschutzerklärung finden.